Urinary metabolites of timolol from humans and laboratory animals. Syntheses and beta-adrenergic blocking activities.
Syntheses are reported for three metabolites (2-4) of timolol (1) formed by oxidative metabolism of the morpholine ring. GLC-MS comparisons are presented which establish that the two metabolites whose structures were previously in question are identical with their synthetic counterparts 2 and 3. In 2, metabolic oxidation of the 4-morpholinyl group of 1 had occurred at the carbon next to oxygen to give the 2-hydroxy-4-morpholinyl moiety, whereas in 3, the morpholine of 1 has been oxidized one step further and then ring opened to produce the N-(2-hydroxyethyl)glycine substituent. Biological testing of synthetic samples of the three major metabolites from human urine (3, 4, and 6) indicated that only 4, in which the morpholine moiety has been degraded to a 2-hydroxyethylamino group, had significant beta-adrenergic blocking activity (one-seventh that of timolol in anesthetized dogs).
D000319:Adrenergic beta-Antagonists; D000818:Animals; D004285:Dogs; D005260:Female; D008401:Gas Chromatography-Mass Spectrometry; D006801:Humans; D007545:Isoproterenol / Q000037:antagonists & inhibitors; D008297:Male; D011412:Propanolamines / Q000652:urine*; D013999:Timolol / Q000031:analogs & derivatives / Q000138:chemical synthesis / Q000494:pharmacology / Q000652:urine*
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; D013999:Timolol; D007545:Isoproterenol